Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Williams Companies Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while Williams Companies Inc trades at $72.47 (market cap $91.21B). The key difference: Williams Companies Inc is far larger — about 2.9× GE HealthCare Technologies Inc. Common Stock's market cap, and Williams Companies Inc pays the higher dividend (2.82%). Which is the better fit depends on your goals.
| GEHC | WMB | |
|---|---|---|
Market Cap | $31.07B | $91.21B |
Volume | 3,443,020 | 6,950,661 |
Sector | Health | Energy |
52-Week High | $88.16 | $79.40 |
52-Week Low | $59.48 | $56.51 |
Enterprise Value | $39.53B | $121.84B |
Dividend Yield | 0.23% | 2.82% |
Typical Hold Time | — | 58 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Williams Companies (WMB) trades at $72.80, down 1.85% on the day, with strong technical momentum indicated by bullish moving averages. The company maintains robust profitability with 25.18% net income margin and 24.02% ROE, supported by $5.9B operating cash flow in 2025. Recent earnings show mixed results with Q1 2026 beating expectations while Q4 2025 and Q2 2026 missed. The stock benefits from positive analyst sentiment with 79% buy ratings and $87.08 consensus price target, representing 20% upside potential.
WMB presents a compelling investment case with strong dividend growth, exposure to rising natural gas demand from AI data centers, and resilient midstream business model. Key risks include energy market volatility, high debt levels at $24.74B long-term debt, and execution challenges in capital-intensive projects. The stock's valuation at 29.71 P/E appears reasonable given growth prospects, but investors should monitor debt management and energy price sensitivity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
